![Mark Lappe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lappe
No más puestos en curso
Fortuna: 96 M $ al 31/05/2026
Perfil
Mark Paul Lappe is the founder of Lappe & Associates, Inc. (1990).
Mr. Lappe is the founder of Efficacy Capital LLC (2004).
Mr. Lappe is the founder of Inhibrx LP (2010).
Mr. Lappe is the founder of Sanofi AATD, Inc. (2010).
Mr. Lappe is also the founder of Efficacy Biotech Fund LP.
Mr. Lappe is currently the Chairman & Chief Executive Officer at Inhibrx Biosciences, Inc. since 2025.
Mr. Lappe is currently the Managing Partner at Efficacy Capital Ltd. since 2003.
Formerly, Mr. Lappe served as Chairman at Repros Therapeutics, Inc. from 2008 to 2009.
Mr. Lappe served as Non-Executive Director at Osmetech Ltd. in 2009.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
6,31 % | 07/04/2026 | 925.413 ( 6,31 % ) | 96 M $ | 31/05/2026 |
Cargos activos de Mark Lappe
| Empresas | Cargo | Inicio |
|---|---|---|
Efficacy Capital Ltd. | Corporate Officer/Principal | 10/06/2009 |
Antiguos cargos conocidos de Mark Lappe.
| Empresas | Cargo | Fin |
|---|---|---|
| INHIBRX, INC. | Director Ejecutivo | 30/05/2024 |
| REPROS THERAPEUTICS INC | Presidente | 12/11/2009 |
Osmetech Ltd.
 Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Director/Miembro de la Junta | 28/08/2009 |
Efficacy Biotech Fund LP | Fundador | - |
Inhibrx LP
 Inhibrx LP BiotechnologyHealth Technology Develops therapeutic antibodies and pharmaceuticals | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
14
Relaciones de 1er grado
8
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat hormonal and reproductive system disorders | Health Technology |
Efficacy Capital Ltd. | |
Efficacy Biotech Fund LP | |
Osmetech Ltd.
Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Health Services |
Lappe & Associates, Inc. | |
Efficacy Capital LLC
 Efficacy Capital LLC Investment ManagersFinance Efficacy Capital invests in US publicly-traded stocks and in fixed-income securities. The firm invests mainly in companies operating in the biotechnology and pharmaceutical industries. | Finance |
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Develops therapeutic antibodies and pharmaceuticals | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
- Bolsa de valores
- Insiders
- Mark Lappe
